Nutra Pharma Corp (NPHC) financial statements (2022 and earlier)

Company profile

Business Address 12538 W. ATLANTIC BLVD.
CORAL SPRINGS, FL 33071
State of Incorp. CA
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments     317
Cash and cash equivalents     317
Receivables 403217153122
Inventory, net of allowances, customer advances and progress billings 5835202654
Inventory 5835202654
Prepaid expense 101763  30
Other undisclosed current assets    32298237
Total current assets: 5558115358185349
Noncurrent Assets
Inventory, Noncurrent 7952    
Operating lease, right-of-use asset 144208
Property, plant and equipment 15711161419
Other noncurrent assets   16161619
Other undisclosed noncurrent assets 916    
Total noncurrent assets: 24628226322938
TOTAL ASSETS: 302340141390214388
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1,3801,1961,3072,3051,9724
Accounts payable 5995834751,302958842
Accrued liabilities 7806138321,0031,0141,130
Employee-related liabilities      956
Taxes payable      1,085
Other undisclosed accounts payable and accrued liabilities      (4,010)
Debt 4,6437,3531,340682889730
Derivative instruments and hedges, liabilities 3,5678361649 
Due to related parties 201123186 52182
Other undisclosed current liabilities 1,6921,4823,1912,8071,6882,838
Total current liabilities: 11,48310,9906,0275,8004,6493,754
Noncurrent Liabilities
Long-term debt and lease obligation 3131,05151   
Long-term debt, excluding current maturities 25390851   
Operating lease, liability 60143
Other undisclosed noncurrent liabilities (60)(143)  42208
Total noncurrent liabilities: 3131,05151 42208
Total liabilities: 11,79612,0416,0785,8004,6913,962
Stockholders' equity
Stockholders' equity attributable to parent (11,494)(11,701)(5,937)(5,410)(4,477)(3,574)
Preferred stock 3333  
Common stock 6,9555,8774,0472,03229580
Additional paid in capital 50,18150,28451,28749,94348,58746,258
Accumulated deficit (68,633)(67,864)(61,273)(57,388)(53,359)(49,912)
Total stockholders' equity: (11,494)(11,701)(5,937)(5,410)(4,477)(3,574)
TOTAL LIABILITIES AND EQUITY: 302340141390214388

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 52104131121168291
Revenue, net 168291
Other income   (2,006)   
Cost of revenue
(Cost of Goods and Services Sold)
 (37)(70)(69)(27)(39)(66)
Other undisclosed gross profit   (48) (184) 
Gross profit: 15351494(55)225
Operating expenses (940)(1,265)(1,893)(1,476)(1,989)(5,992)
Operating loss: (925)(1,230)(1,879)(1,382)(2,044)(5,766)
Nonoperating income (expense) 156(5,362)  19374
Investment income, nonoperating     19 
Other nonoperating income 5    374
Interest and debt expense 1,58793(574)(359)(294)(435)
Income (loss) from continuing operations before equity method investments, income taxes: 818(6,499)(2,453)(1,741)(2,318)(5,827)
Other undisclosed income (loss) from continuing operations before income taxes (1,587)(93)(1,431)(2,288)(1,130)435
Loss from continuing operations before income taxes: (769)(6,591)(3,885)(4,029)(3,448)(5,392)
Income tax expense (benefit)    (1,575)1,270208
Loss before gain (loss) on sale of properties: (769)(6,591)(3,885)(5,604)(2,177)(5,184)
Other undisclosed net income (loss)    1,575(1,270)(208)
Net loss available to common stockholders, diluted: (769)(6,591)(3,885)(4,029)(3,448)(5,392)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (769)(6,591)(3,885)(4,029)(3,448)(5,392)
Comprehensive loss, net of tax, attributable to parent: (769)(6,591)(3,885)(4,029)(3,448)(5,392)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: